SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-010384
Filing Date
2023-03-31
Accepted
2023-03-31 17:01:08
Documents
89
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3014578
2 ex4-1.htm EX-4.1 96025
3 ex21-1.htm EX-21.1 5881
4 ex23-1.htm EX-23.1 3184
5 ex31-1.htm EX-31.1 18115
6 ex31-2.htm EX-31.2 17732
7 ex32-1.htm EX-32.1 6780
8 ex32-2.htm EX-32.2 6669
9 form10-k_001.jpg GRAPHIC 30926
10 form10-k_002.jpg GRAPHIC 53044
11 form10-k_003.jpg GRAPHIC 21311
12 form10-k_004.jpg GRAPHIC 45394
13 form10-k_005.jpg GRAPHIC 23678
14 form10-k_006.jpg GRAPHIC 23173
15 form10-k_007.jpg GRAPHIC 30818
16 form10-k_008.jpg GRAPHIC 11540
17 form10-k_009.jpg GRAPHIC 19841
18 form10-k_010.jpg GRAPHIC 12690
  Complete submission text file 0001493152-23-010384.txt   11252062

Data Files

Seq Description Document Type Size
19 XBRL SCHEMA FILE mymd-20221231.xsd EX-101.SCH 57640
20 XBRL CALCULATION FILE mymd-20221231_cal.xml EX-101.CAL 59836
21 XBRL DEFINITION FILE mymd-20221231_def.xml EX-101.DEF 303386
22 XBRL LABEL FILE mymd-20221231_lab.xml EX-101.LAB 514974
23 XBRL PRESENTATION FILE mymd-20221231_pre.xml EX-101.PRE 409039
83 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1665971
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36268 | Film No.: 23788939
SIC: 2835 In Vitro & In Vivo Diagnostic Substances